Gravar-mail: AT-12 THE ROLE OF HIGH-DOSE MYELOABLATIVE CHEMOTHERAPY (HDCT) WITH HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN CHILDREN WITH ATYPICAL TERATOID RHABDOID TUMOURS (AT/RT): RESULTS OF A SYSTEMATIC REVIEW